Testimony
Written comments to FDA April 30, 2019
The following written comments were submitted to the Dockets Management Staff (HFA-305) Food and Drug Administration by IFFGD President, Ceciel T. Rooker, in response to Docket No. FDA-2019-N-0077 on April 30, 2019. SUMMARY On behalf of the millions of Americans living with a rare gastrointestinal (GI) illness, the International Foundation for Gastrointestinal Disorders (IFFGD) thanks […]